Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal
Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro surged in the first quarter.
You are not logged in so some information on this page has been withheld. To see more, please log in.
Zepbound
since
auto-detected in 99 stories
55 days ago
64 days ago
Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro
Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.
82 days ago
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.
85 days ago
Hims & Hers shares rise as company adds new weight-loss medications to platform
Hims & Hers is adding Zepbound, Mounjaro, and the generic injection liraglutide to its platform.
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
found
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.
3 months ago
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound
found
Telehealth firms Teladoc and LifeMD said they signed an agreement with Eli Lilly's pharmacy partner to offer patients the weight-loss drug, Zepbound.
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.